Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-25

Clinical Trial Update: Liposomal Bupivacaine Versus Bupivacaine Plain for Operative Pain Management of Forefoot Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing liposomal bupivacaine to plain bupivacaine for operative pain management in forefoot surgery; status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (plain) (bupivacaine)
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Alexandra Black | Conditions: Liposomal Bupivacaine, Postoperative Pain | Phase 4 | Status: UNKNOWN